SCHEMBL14732425

SCHEMBL14732425

c1ccc2c(c1)[nH]c1sc3ccncc3c12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.53
GABRA1 P14867 5/20 0.49
GABRG2 P18507 5/20 0.49
GABRB3 P28472 5/20 0.49
GABRA5 P31644 5/20 0.49
GABRA3 P34903 5/20 0.49
GABRA2 P47869 5/20 0.49
KDM4E B2RXH2 2/20 0.49
ALDH1A1 P00352 2/20 0.49
HPGD P15428 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
GABRP O00591 2/20 0.49
GABRD O14764 2/20 0.49
GABRB1 P18505 2/20 0.49
GABRB2 P47870 2/20 0.49
GABRA4 P48169 2/20 0.49
GABRE P78334 2/20 0.49
GABRA6 Q16445 2/20 0.49
GABRG1 Q8N1C3 2/20 0.49
GABRG3 Q99928 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16751749 0.88 GABRA1 (0.53) ACHEGABRA1GABRG2GABRB3GABRA5
SCHEMBL573921 0.81 TNKS (0.59) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL31606611 0.81 TNKS (0.59) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL16751650 0.76 GABRA1 (0.46) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL16751745 0.74 GABRA1 (0.45) ACHEGABRA1GABRG2GABRB3GABRA5
SCHEMBL16751693 0.73 GABRA1 (0.48) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL16751751 0.72 GABRA1 (0.55) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL24767865 0.72 MEN1 (0.51) ACHEGABRA1GABRG2GABRB3GABRA5
SCHEMBL29848469 0.72 MEN1 (0.51) ACHEGABRA1GABRG2GABRB3GABRA5
SCHEMBL16751689 0.71 GABRA1 (0.50) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9139582-B2 Organic electroluminescent devices MERCK PATENT GMBH (DE) 2015-09-22 US disclosed
US-9139582-B2 Organic electroluminescent devices MERCK PATENT GMBH (DE) 2015-09-22 US disclosed
WO-2015076600-A1 NOVEL LIGHT EMISSION COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME 주식회사 동진쎄미켐 2015-05-28 WO disclosed
US-20130053555-A1 ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2013-02-28 US disclosed
US-20130053555-A1 ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053555-A1 ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, PIEZO1, OR10J3 ACHE 637/4885GABRA1 2321/4885GABRG2 2730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.